Steen Lisby - SVP & CHIEF SCIENTIFIC OFFICER at Y-mAbs Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	35.6K	$71.2K	$2.00	Jan 18, 2024	Direct
Employee Stock Option (right to buy)	35.7K			Jan 18, 2024	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.